Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains.
Bermejo-Martin
Jesús F
JF
National Centre of Influenza, Valladolid, Spain. jbermejo@hcuv.sacyl.es
Kelvin
David J
DJ
Eiros
Jose María
JM
Castrodeza
Javier
J
Ortiz de Lejarazu
Raúl
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000302:isolation & purification*; D007251:Influenza, Human / Q000150:complications* / Q000188:drug therapy* / Q000821:virology; D018942:Macrolides / Q000627:therapeutic use*; D018410:Pneumonia, Bacterial / Q000150:complications* / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D018942:Macrolides